MedPath
HSA Product

Sunlenca solution for injection 463.5mg/1.5ml

Product approved by Health Sciences Authority (SG)

Basic Information

Sunlenca solution for injection 463.5mg/1.5ml

INJECTION, SOLUTION

Regulatory Information

SIN17189P

February 27, 2025

Prescription Only

Therapeutic

SUBCUTANEOUS

May 23, 2025

June 3, 2025

Company Information

GILEAD SCIENCES SINGAPORE PTE. LTD.

Active Ingredients

Lenacapavir Sodium eqv Lenacapavir

Strength: 463.5mg/1.5ml

© Copyright 2025. All Rights Reserved by MedPath